Home > Drug Search >
  • Targets: Cytochrome P450 family 3 subfamily A member 4 (CYP3A4)
  •   > 
Drug Filter
Status:
Approved (4) Phase Ⅲ (2) Phase Ⅱ (9) Phase Ⅰ (4)
Clinical Stage:
Pending (4) Active (4) Discontinued (7)
Company:
Daiichi Sankyo (1) Denovo Biopharma (1) Eisai (1) GlaxoSmithKline (1) Lilly (5) National Cancer Institute (1) Otsuka (2) Pfizer (1) Roche (1) Sanofi (1) Taisho Pharmaceutical (2) City of Hope National Medical Center (1) Sarepta Therapuetics (1) Rexahn Pharmaceuticals (1) BrainCells (2) Ionis Pharmaceuticals (1) AstraZeneca (1) Celgene (1)
Indication:
Acute myeloid Leukemia (AML) (2) Anxiety (1) Bladder cancer (1) Cognitive disorders (1) Contrast agents (1) Depression (2) HBV infection (1) Hematopoietic stem cell transplantation (HSCT) (1) Hepatocellular carcinoma (HCC) (1) Major depressive disorder (MDD) (1) Myelodysplastic syndrome (MDS) (2) Ovarian cancer (1) Pancreatic cancer (1) Schizophrenia (2) Solid tumours (1) Pain (1) Stroke (1) Anesthesia (1) Acute ischemic stroke (AIS) (1) Post-traumatic stress disorder (1) Thrombosis (1) Panic disorder (1) Pharmaceutical aids (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top